Jeffersonville, PA, United States of America

Keith C Mozzone


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keith C. Mozzone: Innovator in Pharmaceuticals

Introduction

Keith C. Mozzone, based in Jeffersonville, Pennsylvania, has made significant strides in the field of pharmaceuticals. With a keen focus on developing novel formulations, he holds a patent that exemplifies his innovative spirit and dedication to enhancing medical therapies.

Latest Patents

Keith C. Mozzone is the inventor of a patent titled "Calcitonin Suppository Formulations." This invention discloses unique rectal and vaginal suppository formulations that comprise calcitonin and caprylic acid monoglyceride, all within a pharmaceutically acceptable suppository vehicle. This innovative formulation aims to improve the delivery and effectiveness of calcitonin treatments.

Career Highlights

Keith is associated with Rorer Pharmaceutical Corporation, where he contributes his expertise to the development of cutting-edge pharmaceutical products. His work aligns with the company's mission to advance healthcare through innovative solutions.

Collaborations

Throughout his career, Keith has collaborated with talented individuals such as Abdur R. Purkaystha and Gary G. Gazdick. These collaborations highlight the importance of teamwork in driving innovation and achieving breakthrough solutions in pharmaceutical science.

Conclusion

In summary, Keith C. Mozzone stands out as a prominent inventor in the pharmaceutical industry. His patent on calcitonin suppository formulations showcases his ability to blend scientific knowledge with practical applications, ultimately benefiting patient care and advancing medical treatment options. His contributions reflect a commitment to innovation and collaboration in the ever-evolving field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…